Local News

Voyager Adds Alzheimer's Experts To Its Scientific Advisory Board

Posted Updated

RALEIGH, N.C. — Voyager Pharmaceuticals

is adding six experts in Alzheimer's disease treatment and research to its scientific board of advisors.

Voyager is seeking to develop a drug to treat Alzheimer's.

Board members include: Steven DeKoskym an MD, who chairs toe department of neurology at the University of Pittsburgh and directs the university's Alzheimer's research center; Rachelle Doody, MD, director of the Alzheimer's disease and memory discord center at the Baylor College of Medicine; Mary Sano, PhD, director of the Alzheimer's disease research center at the Mount Sinai School of Medicine.

Also: Lon Schneider, MD, director of the Alzheimer Research and Clinical Center of California; Leon Thal, MD, Florence Riford Chair in Alzheimer's disease at the University of California San Diego; and Bengt Winbald, MD, chief physician at Karolinska University Hospital in Sweden.

Copyright 2023 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.